Despite limited evidence, longevity enthusiasts are exploring SGLT2 inhibitors in their pursuit of healthier, longer lives.
Some health-conscious Americans believe the next breakthrough in anti-aging might already be sitting in the medicine cabinets of millions of people with diabetes. Read More.
